Bente Vilming Elgaaen

Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker

Bente Vilming Elgaaen, Ole Kristoffer Olstad, Kari Bente Foss Haug et al. · BMC Cancer · 2014 · 117 citations · Full text

Medicine, Cancer Biology, Oncology +17

ZNF385B and VEGFA Are Strongly Differentially Expressed in Serous Ovarian Carcinomas and Correlate with Survival

Bente Vilming Elgaaen, Ole Kristoffer Olstad, Leiv Sandvik et al. · PLoS ONE · 2012 · 50 citations · Full text

Medicine, Gynecology, Oncology +17

POLD2 and KSP37 (FGFBP2) Correlate Strongly with Histology, Stage and Outcome in Ovarian Carcinomas

Bente Vilming Elgaaen, Kari Bente Foss Haug, Junbai Wang et al. · PLoS ONE · 2010 · 40 citations · Full text

Medicine, Oncology, Pathology +17

Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells’ sensitivity to paclitaxel

Mahesh Tambe, Sofia Pruikkonen, Jenni H. Mäki-Jouppila et al. · Oncotarget · 2016 · 39 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma

Ben Davidson, Dag André Nymoen, Bente Vilming Elgaaen et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2014 · 33 citations

Medicine, Genetics, Oncology +15